Form D Explorer
Evofem Biosciences, Inc. · CIK 1618835

Report a data issueCitable research briefCompare issuerPrivate research collection

Evofem Biosciences, Inc.

CIK 1618835 · Corporation · Inc. DELAWARE · SAN DIEGO, California · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Apr 15, 2025
through Jul 2, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldApr 15, 2025 · DJul 2, 2025 · DLater minus earlier
Reported offering amount$1,500,000$925,000$-575,000
Reported amount sold$750,000$925,000$175,000
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001641172-25-004770 · Later SEC source: 0001641172-25-017535

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Jul 2, 2025

Reported offering amount
$925,000
Reported exemptions
Rule 506(b)
Reported amount sold
$925,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)